1. Lis K, Kuzawińska O, Bałkowiec-Iskra E. Tumor necrosis factor inhibitors -state of knowledge. Arch Med Sci. 2014;10(6):1175-85. doi: 10.5114/aoms.2014.47827;
2. Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12(1):49-62. doi: 10.1038/nrrheum.2015.169;
3. Mitoma H, Horiuchi T, Tsukamoto H, Ueda N. Molecular mechanisms of action of anti-TNF-a agents-comparison among therapeutic TNF-a antagonists. Cytokine. 2018;101:56-63. doi: 10.1016/j.cyto.2016.08.014;
4. Billmeier U, Dieterich W, Neurath MF, Atreya R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol. 2016;22(42): 9300-13. doi: 10.3748/wjg.v22.i42.9300;
5. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72:3666-70;